SCHEMBL30985685

SCHEMBL30985685

CCCCP(C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2.CCCCP(C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2.[Pd+2]

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.37
HSD11B1 P28845 1/20 0.33
KMT2A Q03164 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GRIN2D O15399 4/20 0.30
GRIN3B O60391 4/20 0.30
GRIN1 Q05586 4/20 0.30
GRIN2A Q12879 4/20 0.30
GRIN2B Q13224 4/20 0.30
GRIN2C Q14957 4/20 0.30
GRIN3A Q8TCU5 4/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20077560 0.98 EPHX2 (0.38) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL128692 0.98 EPHX2 (0.38) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL19588665 0.98 EPHX2 (0.38) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL20067101 0.98 EPHX2 (0.38) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL27367847 0.98 EPHX2 (0.38) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
Iodide SCHEMBL237045 0.96 EPHX2 (0.37) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL31373110 0.96 EPHX2 (0.37) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL30454549 0.96 EPHX2 (0.37) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
SCHEMBL31296126 0.96 EPHX2 (0.37) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D
Bromide SCHEMBL28905083 0.96 EPHX2 (0.37) EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397664-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2024-07-10 EP disclosed